Gabor Kokeny
Overview
Explore the profile of Gabor Kokeny including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nemeth A, Mozes M, Calvier L, Hansmann G, Kokeny G
BMC Nephrol
. 2019 Jul;
20(1):245.
PMID: 31277592
Background: It has been proposed that peroxisome proliferator-activated receptor-γ (PPARγ) agonists might reduce renal fibrosis, however, several studies had contradictory results. Moreover, the possible interaction of TGF-β, PPARγ, and transcription...
12.
Calvier L, Chouvarine P, Legchenko E, Kokeny G, Mozes M, Hansmann G
Am J Respir Cell Mol Biol
. 2019 Jul;
61(1):121-123.
PMID: 31259625
No abstract available.
13.
Benke K, Matyas C, Sayour A, Olah A, Nemeth B, Ruppert M, et al.
Sci Rep
. 2017 Oct;
7(1):14232.
PMID: 29079777
While heart transplantation (HTX) is the definitive therapy of heart failure, donor shortage is emerging. Pharmacological activation of soluble guanylate cyclase (sGC) and increased cGMP-signalling have been reported to have...
14.
Czirok S, Fang L, Radovits T, Szabo G, Szenasi G, Rosivall L, et al.
Sci Rep
. 2017 Sep;
7(1):11218.
PMID: 28894114
Decreased soluble guanylate cyclase activity and cGMP levels in diabetic kidneys were shown to influence the progression of nephropathy. The regulatory effects of soluble guanylate cyclase activators on renal signaling...
15.
Gasparics A, Kokeny G, Fintha A, Bencs R, Mozes M, Agoston E, et al.
Pathol Oncol Res
. 2017 Aug;
24(3):641-651.
PMID: 28815470
Suppressor of cancer cell invasion (SCAI) has been originally characterized as a tumor suppressor inhibiting metastasis in different human cancer cells, and it has been suggested that SCAI expression declines...
16.
Mozes M, Szoleczky P, Rosivall L, Kokeny G
BMC Nephrol
. 2017 Jul;
18(1):209.
PMID: 28673338
Background: Although TGF-ß and the transcription factor Egr-1 play an important role in both kidney fibrosis and in response to acute changes of renal medullary osmolarity, their role under sustained...
17.
Kokeny G, Fang L, Revesz C, Mozes M, Voros P, Szenasi G, et al.
Kidney Blood Press Res
. 2017 Mar;
42(1):109-122.
PMID: 28359068
Background/aims: Diabetic nephropathy remains a major clinical problem. The effects of prorenin might be adverse, but the literature data are controversial. We compared the renal effects of the (pro)renin receptor...
18.
Haris A, Polner K, Aranyi J, Braunitzer H, Kaszas I, Rosivall L, et al.
BMC Nephrol
. 2017 Feb;
18(1):76.
PMID: 28231769
Background: The early identification of patients with ANCA-associated vasculitis (AAV) who are at increased risk for inferior clinical outcome at the time of diagnosis might help to optimize the immunosuppressive...
19.
Matyas C, Nemeth B, Olah A, Torok M, Ruppert M, Kellermayer D, et al.
Eur J Heart Fail
. 2016 Dec;
19(3):326-336.
PMID: 27995696
Aims: Heart failure with preserved ejection fraction (HFpEF) has a great epidemiological burden. The pathophysiological role of cyclic guanosine monophosphate (cGMP) signalling has been intensively investigated in HFpEF. Elevated levels...
20.
Nemeth B, Matyas C, Olah A, Lux A, Hidi L, Ruppert M, et al.
Sci Rep
. 2016 Nov;
6:37166.
PMID: 27853261
Pathologic myocardial hypertrophy develops when the heart is chronically pressure-overloaded. Elevated intracellular cGMP-levels have been reported to prevent the development of pathologic myocardial hypertrophy, therefore we investigated the effects of...